Clarithromycin plus intravenous immunoglobulin therapy can reduce the relapse rate of Kawasaki disease: A phase 2, open-label, randomized control study

Etsuro Nanishi, Hisanori Nishio, Hidetoshi Takada, Kenichiro Yamamura, Mitsuharu Fukazawa, Kenji Furuno, Yumi Mizuno, Kenjiro Saigo, Ryo Kadoya, Noriko Ohbuchi, Yasuhiro Onoe, Hironori Yamashita, Hideki Nakayama, Takuya Hara, Takuro Ohno, Yasuhiko Takahashi, Ken Hatae, Tatsuo Harada, Takayuki Shimose, Junji KishimotoShouichi Ohga, Toshiro Hara

研究成果: Contribution to journalArticle査読

2 被引用数 (Scopus)

フィンガープリント

「Clarithromycin plus intravenous immunoglobulin therapy can reduce the relapse rate of Kawasaki disease: A phase 2, open-label, randomized control study」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Medicine & Life Sciences